Cardiac MRI in Ischemic Stroke Study
CaMriSS
2 other identifiers
observational
103
1 country
2
Brief Summary
The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2012
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 7, 2012
CompletedFirst Posted
Study publicly available on registry
August 7, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedNovember 8, 2016
November 1, 2016
2.8 years
August 7, 2012
November 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity and specificity of contrast medium-enhanced cardiac magnetic resonance imaging to detect echocardiography-proven cardiac sources of embolism in patients with acute ischemic stroke.
< 1 week after ischemic stroke
Secondary Outcomes (1)
Rate of unrecognised myocardial infarction detected by late gadolinium-enhanced cardiac MRI in patients with acute ischemic stroke.
< 1 week after ischemic stroke
Eligibility Criteria
Overall, 103 patients with acute ischemic stroke detected by brain magnetic resonance imaging will be enrolled.
You may qualify if:
- Patients with acute ischemic stroke detected by brain magnetic resonance imaging.
You may not qualify if:
- Known atrial fibrillation or cardiac source of embolism
- Severe aphasia
- Acute infection or chronic inflammation
- Severe arteriosclerosis or stenosis of brain-supplying arteries
- Contraindications for magnetic resonance imaging or transesophageal echocardiography.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin
Berlin, 12203, Germany
Elisabeth Hospital
Essen, Germany
Related Publications (1)
Haeusler KG, Wollboldt C, Bentheim LZ, Herm J, Jager S, Kunze C, Eberle HC, Deluigi CC, Bruder O, Malsch C, Heuschmann PU, Endres M, Audebert HJ, Morguet AJ, Jensen C, Fiebach JB. Feasibility and Diagnostic Value of Cardiovascular Magnetic Resonance Imaging After Acute Ischemic Stroke of Undetermined Origin. Stroke. 2017 May;48(5):1241-1247. doi: 10.1161/STROKEAHA.116.016227. Epub 2017 Apr 14.
PMID: 28411261DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Prof. Matthias Endres, MD
Center for Stroke Research Berlin
- PRINCIPAL INVESTIGATOR
Karl Georg Haeusler, MD
Center for Stroke Research Berlin
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 7, 2012
First Posted
August 7, 2013
Study Start
January 1, 2012
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
November 8, 2016
Record last verified: 2016-11